Li Chuling, Chen Yijin, Chen Qiqi, Huang Haoxiang, Hesse Michael, Zhou Yilin, Jin Ming, Liu Yu, Ruan Yifei, He Xiang, Wei Guoquan, Zheng Hao, Huang Senlin, Chen Guojun, Liao Wangjun, Liao Yulin, Chen Yanmei, Bin Jianping
Department of Cardiology, State Key Laboratory of Organ Failure Research, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
Guangdong Provincial Key Laboratory of Cardiac Function and Microcirculation, Guangzhou, 510515, China.
Adv Sci (Weinh). 2025 Jan;12(2):e2402371. doi: 10.1002/advs.202402371. Epub 2024 Nov 19.
Stimulating cardiomyocyte (CM) dedifferentiation and cell cycle activity (DACCA) is essential for triggering daughter CM formation. In addition to transcriptional processes, RNA-binding proteins (RBPs) are emerging as crucial post-transcriptional players in regulating CM DACCA. However, whether post-transcriptional regulation of CM DACCA by RBPs could effectively trigger daughter CM formation remains unknown. By performing integrated bioinformatic analysis of snRNA-seq data from neonatal and adult hearts, this study identified Hnrnpa1 as a potential RBP regulating CM DACCA. Hnrnpa1 expression decreased significantly during postnatal heart development. With the use of α-MHC-H2B-mCh/CAG-eGFP-anillin transgenic mice, Hnrnpa1 overexpression promoted CM DACCA, thereby triggering daughter CM formation and enhancing cardiac repair after myocardial infarction (MI). In contrast, CRISPR/Cas9 technology is used to generate CM-specific Hnrnpa1 knockout mice. Hnrnpa1 knockout inhibited cardiac regeneration and worsened cardiac function in the neonatal MI model. Nanopore RNA sequencing, RIP assay, IP-MS, MeRIP-qPCR, PAR-CLIP and luciferase reporter experiments showed that Hnrnpa1 induced Mettl3 post-transcriptional splicing to inhibit m6A-dependent Pbx1 and E2F1 degradation, thereby increasing Runx1, Ccne1, Cdk2 and Ccnb2 expression to promote CM DACCA. In conclusion, Hnrnpa1 triggered daughter CM formation by promoting CM DACCA in a post-transcriptional manner, indicating that Hnrnpa1 might serve as a promising target in cardiac repair post-MI.
刺激心肌细胞(CM)去分化和细胞周期活性(DACCA)对于触发子代CM形成至关重要。除转录过程外,RNA结合蛋白(RBP)正成为调节CM DACCA的关键转录后因子。然而,RBP对CM DACCA的转录后调控是否能有效触发子代CM形成仍不清楚。通过对来自新生和成年心脏的snRNA-seq数据进行综合生物信息学分析,本研究确定Hnrnpa1为调节CM DACCA的潜在RBP。Hnrnpa1表达在出生后心脏发育过程中显著下降。利用α-MHC-H2B-mCh/CAG-eGFP-膜收缩蛋白转基因小鼠,Hnrnpa1过表达促进CM DACCA,从而触发子代CM形成并增强心肌梗死后的心脏修复。相反,使用CRISPR/Cas9技术构建CM特异性Hnrnpa1敲除小鼠。在新生心肌梗死模型中,Hnrnpa1敲除抑制心脏再生并恶化心脏功能。纳米孔RNA测序、RIP分析、IP-MS、MeRIP-qPCR、PAR-CLIP和荧光素酶报告实验表明,Hnrnpa1诱导Mettl3转录后剪接以抑制m6A依赖的Pbx1和E2F1降解,从而增加Runx1、CcneI、Cdk2和Ccnb2表达以促进CM DACCA。总之,Hnrnpa1通过转录后促进CM DACCA触发子代CM形成,表明Hnrnpa1可能是心肌梗死后心脏修复的一个有前景的靶点。